Cromos Pharma, where the patients are

Drug Sponsors

Unigene secures financing to extend operations, cuts 40% of staff

Tuesday, April 9, 2013 08:00 AM

Unigene Laboratories, a biopharmaceutical company focused on peptide-based therapeutics, has entered into a second amendment to a financing agreement with affiliates of Victory Park Capital Advisors (VPC), whereby VPC has agreed to purchase an additional $750,000 senior secured note, providing Unigene with additional working capital.

More... »

CRF Health eCOA webinar series

Merz Pharma Group withdraws proposal to acquire Obagi

Monday, April 8, 2013 02:01 PM

Merz Pharma Group has withdrawn its non-binding proposal to acquire all of the outstanding common stock of Obagi Medical Products for $22 per share in cash.

More... »

Bourne Partners, Covis Pharma acquire U.S. rights for five drugs from Sanofi

Monday, April 8, 2013 11:34 AM

Covis Pharma, a Switzerland-based specialty pharmaceutical company, has formed an agreement with Sanofi-Aventis and certain affiliates to acquire full commercial rights for Nilandron (nilutamide), Plaquenil (hydroxychloroquine), Rilutek (riluzole), Uroxatral (alfuzosin hydrochloride) and Kayexalate (sodium polystyrene sulfate) in the U.S.  

More... »

Regeneron Pharmaceuticals to expand headquarters, create 400 jobs

Friday, April 5, 2013 11:07 AM

Regeneron Pharmaceuticals, a science-based biopharmaceutical company based in Tarrytown, N.Y., will expand its corporate headquarters and create more than 400 new high-skill jobs. 

More... »

Elan closes Tysabri collaboration transaction with Biogen Idec

Wednesday, April 3, 2013 03:17 PM

Elan, a biotechnology company based in Ireland, has closed its Tysabri (natalizumab) collaboration transaction with Biogen Idec, which was originally announced on February 6, 2013.

More... »

MedImmune aquires Alphacore Pharma

Wednesday, April 3, 2013 02:20 PM

MedImmune, AstraZeneca’s global biologics R&D arm, has acquired AlphaCore Pharma, an Ann Arbor, Mich.-based biotechnology company focused on the development of ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme.

More... »

GSK publishes 2012 corporate responsibility report

Wednesday, April 3, 2013 10:18 AM

GlaxoSmithKline has published its Corporate Responsibility Report, in which it reiterates its commitment to operate responsibly, openly and transparently and outlines advances made on this agenda during 2012.

More... »

T2 Biosystems completes $40M Series E financing for T2Candida clinical programs

Friday, March 29, 2013 12:26 PM

Lexington, Mass.-based T2 Biosystems has completed a $40 million financing to support the clinical programs and commercialization of T2Candida, the Company's flagship molecular diagnostic test panel for the sensitive and rapid identification of species-specific Candida fungal infections directly from whole blood.

More... »

Actavis to expand Florida manufacturing facility, create 220 jobs

Wednesday, March 27, 2013 10:55 AM

Actavis, a specialty pharmaceutical company formerly known as Watson Pharmaceuticals, plans to expand its pharmaceutical manufacturing and warehousing facilities in Davie, Fla., resulting in the creation of 220 jobs.

More... »

Ziopharm terminates development of palifosfamide in metastatic soft tissue sarcoma

Wednesday, March 27, 2013 09:57 AM

Ziopharm Oncology, a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced that its phase III trial of palifosfamide (ZIO-201) for the treatment of metastatic soft tissue sarcoma in the first-line setting (PICASSO 3) did not meet its primary endpoint of progression-free survival (PFS).

More... »

CenterWatch Data Library



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs